NEW YORK, Oct. 22 (GenomeWeb News) – Large Scale Biology reported revenues of $1.2 million for the third quarter, compared to $0.7 million in the same period last year.

The Vacaville, Calif., company had a net loss of $4.3 million for the quarter, compared to $6.8 million for the third quarter of 2002.

LSBC's R&D expenses decreased to $2.8 million, from $4.5 million in the year-ago quarter.

At the end of the third quarter, the company had $11.3 million in cash and marketable securities.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.